Skip to main content

RAP-041 mediated modulation of intratumoral immune cell subpopulations in vivo and effect of combination treatment with anti-PD1 monoclonal antibody

Research Grant
Duke Scholars

Administered By

Medicine, Medical Oncology

Awarded By

Acceleron Pharma

Start Date

September 27, 2016

End Date

September 26, 2018
 

Administered By

Medicine, Medical Oncology

Awarded By

Acceleron Pharma

Start Date

September 27, 2016

End Date

September 26, 2018